Nikko Asset Management Americas, Inc. Abb Vie Inc. Transaction History

Nikko Asset Management Americas, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $6.66 Million - $7.4 Million	-74,909 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $5.69 Million - $6.74 Million	63,405 Added 551.16%	74,909 $6.94 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $1.06 Million - $1.42 Million	11,504 New	11,504 $1.09 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $698,568 - $766,038	-7,800 Closed	0 $0
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $544,830 - $695,916	7,800	7,800 $693,000

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.